This level of vertical integration will definitely work in our favor. I looked at Nuray again and noticed that they are an API supplier of psilocybin. Seems like there are less than a handful of them. This may be lucrative as this product goes mainstream. I would guess that there is a lack of FDA know-how among the various start up looking to enter here.
News 
Market Data 
Discover 
